Kriti Nutrients Ltd. Publishes Q3 FY26 Unaudited Financial Results
Kriti Nutrients Limited reported unaudited results for Q3 FY26. Standalone total income from operations was ₹13,619.67 lakhs, with a net loss after tax of ₹49.49 lakhs for the quarter. Consolidated total income from operations was ₹13,603.29 lakhs, with a net loss after tax of ₹38.38 lakhs for the quarter.
The announcement pertains to financial results, which directly impacts investor and market perception. However, the losses are not extremely severe, hence the medium impact.
The company reported net losses for both standalone and consolidated results for the quarter and nine months ended December 31, 2025.
Kriti Nutrients Limited has announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The results were published in the newspapers Chautha Sansar and Business Standard on February 7, 2026.
The company reported total income from operations of ₹13,619.67 lakhs for the standalone quarter ended December 31, 2025, compared to ₹21,055.51 lakhs in the same quarter of the previous year. For the nine months ended December 31, 2025, the standalone total income from operations stood at ₹44,757.41 lakhs.
On a consolidated basis, the total income from operations for the quarter ended December 31, 2025, was ₹13,603.29 lakhs, down from ₹21,056.10 lakhs in the corresponding quarter of the previous year. The consolidated nine-month income from operations was ₹44,759.48 lakhs.
The company reported a net loss after tax of ₹49.49 lakhs for the standalone quarter ended December 31, 2025. For the nine months ended December 31, 2025, the standalone net loss after tax was ₹300.10 lakhs.
On a consolidated basis, Kriti Nutrients Limited posted a net loss after tax of ₹38.38 lakhs for the quarter ended December 31, 2025. The consolidated net loss after tax for the nine months ended December 31, 2025, was ₹263.88 lakhs.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.